Algorithm-Based Approach to the Histological Routine Diagnosis of Renal Oncocytic Tumors in Core Biopsy Specimens.
Chromophobe renal cell carcinoma
Core biopsy
Differential diagnosis
Immunohistochemistry
Oncocytic tumor
Oncocytoma
Journal
Current urology reports
ISSN: 1534-6285
Titre abrégé: Curr Urol Rep
Pays: United States
ID NLM: 100900943
Informations de publication
Date de publication:
Nov 2022
Nov 2022
Historique:
accepted:
11
07
2022
pubmed:
29
9
2022
medline:
15
12
2022
entrez:
28
9
2022
Statut:
ppublish
Résumé
A growing number of tumor entities with badly defined limits are enlarging in the last years the family of oncocytic tumors in the kidney. Chromophobe renal cell carcinoma (ChRCC) and renal oncocytoma (RO) are classically well-known tumors, but the borderland between them, and their precise connection, remains a matter of debate. Aside from that, other emerging and provisional entities, like eosinophilic solid and cystic renal cell carcinoma (ESC RCC), eosinophilic vacuolated tumor (EVT), low-grade oncocytic tumor (LOT), and papillary renal neoplasm with reverse polarity (PRRP), have been recently described. This spectrum of tumors remains a diagnostic challenge in renal pathology, especially if the specimen obtained is scarce. This review focuses on practical diagnostic problems when managing core biopsies and proposes a diagnostic algorithm maximizing the information provided by both morphology and immunohistochemistry. So, a combination of morphologic features on hematoxylin-eosin and six antibodies (CK7, CD117, CK20, CD10, GATA-3, and cathepsin K) is advised to be used in a stepwise fashion.
Identifiants
pubmed: 36169870
doi: 10.1007/s11934-022-01114-9
pii: 10.1007/s11934-022-01114-9
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
327-333Informations de copyright
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.